Shoon Lae Maw. Development of a simple HPLC method for determination of urinary O-Aminohippuric Acid (OAH) and an Establishment of OAH reference interval. Master's Degree(Medical Technology). Chiang Mai University. Library. : Chiang Mai University, 2024.
Development of a simple HPLC method for determination of urinary O-Aminohippuric Acid (OAH) and an Establishment of OAH reference interval
Abstract:
O-aminohippuric acid (OAH) is considered as a low-abundance urinary fluorescent metabolite with potential as an innovative lung cancer biomarker. A recent method for measuring OAH is high-performance liquid chromatography (HPLC) mass spectrometry and nuclear magnetic resonance spectroscopy. These methods are laborintensive and expensive for routine measurement. Thus, a simple method for the determination of urinary OAH is needed. The amount of urinary OAH needs to be normalized by urinary creatinine which is produced at a constant rate. The newly developed method must be able to determine urinary creatinine and OAH in the same run. This work aimed to develop and validate a simple analytical HPLC method for urinary OAH measurement and to establish the reference intervals of OAH in healthy individuals. Moreover, the standard OAH was synthesized in our laboratory. Analysis was performed on a reverse-phase C18 (150 x 4.6 mm, 5 µm) column with a gradient elution system consisting of ammonium acetate buffer (pH 6.5, 100 mM) (A) and acetonitrile (B). Total run time was 27 minutes including equilibration time with 1 mL/min constant flow rate. The column temperature was maintained at 40°C and the sample injection volume was 10 µL. The quantification of both analytes was performed at the same time using a diode array detector (DAD) with a detection wavelength of 235 nm for creatinine and a fluorescent detector (FLD) with a detection wavelength at excitation 340 nm, emission of 430 nm for OAH. After the implementation of optimal conditions, the procedure was compiled according to ICH validation parameters. The obtained linear ranges of the calibration curves were 0.1 1000 µg/mL for creatinine and 0.1 100 µg/mL for OAH. The recoveries ranged between 91.35 % and 109.12%. The relative standard deviations (RSDs) for the intra-day and inter-day results ranged from 0.11 0.66 % to 0.16 1.73 %, respectively. The limits of detection (LOD) and quantification (LOQ) were 0.258 µg/mL and 0.783 µg/mL for creatinine while LOD and LOQ for OAH were 0.045 µg/mL and 0.137 µg/mL, respectively. The method was successfully applied to establish reference intervals of OAH in healthy individuals and was defined 0.420 2.287 mmol/mol creatinine. Increasing urinary levels of OAH metabolite displayed a weak positive association with age (r = 0.347, p = 0.000) and higher values were found in elder-aged group (over 60 years). However, OAH itself did not depend on smoking status (r = -0.142, p = 0.123). According to those various validate parameters: the proposed method was proved to be able to quantify urinary OAH and creatinine in a single run. It can also be analyzed non-invasively without additional sample processing. Reported herein is the first establishment of OAH reference intervals in healthy individuals and may be benefit to the utilization of OAH as a non-invasive biomarker for lung cancer detection in the future.